Back to search

Article

Exploiting a metabolic vulnerability in brain tumour stem cells using a brain-penetrant drug with safe profile

2024-01-16

Abstract excerpt

Glioblastoma (GB) remains one of the most treatment refractory and fatal tumour in humans. GB contains a population of self-renewing stem cells, the brain tumour stem cells (BTSC) that are highly resistant to therapy and are at the origin of tumour relapse. Here, we report, for the first time, that mubritinib potently impairs stemness and growth of patient-derived BTSCs harboring different oncogenic mutations. Mec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8566804-be96-5dcb-b8a8-d7a467950053
DOI
10.1101/2024.01.15.574967
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploiting a metabolic vulnerability in brain tumour stem cells using a brain-penetrant drug with safe profileDOI 10.1101/2024.01.15.574967
Select a neighboring publication to make it the new centre.